These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

354 related items for PubMed ID: 18495263

  • 21. Combination antiplatelet agents for secondary prevention of ischemic stroke.
    Vande Griend JP, Saseen JJ.
    Pharmacotherapy; 2008 Oct; 28(10):1233-42. PubMed ID: 18823219
    [Abstract] [Full Text] [Related]

  • 22. [The Polypill: between myths and reality in the treatment of type 2 diabetes mellitus].
    Ruiz J, Egli M.
    Rev Med Suisse; 2006 May 31; 2(68):1480-2, 1484-5. PubMed ID: 16783994
    [Abstract] [Full Text] [Related]

  • 23. Comparison of increased aspirin dose versus combined aspirin plus clopidogrel therapy in patients with diabetes mellitus and coronary heart disease and impaired antiplatelet response to low-dose aspirin.
    Duzenli MA, Ozdemir K, Aygul N, Soylu A, Tokac M.
    Am J Cardiol; 2008 Aug 15; 102(4):396-400. PubMed ID: 18678294
    [Abstract] [Full Text] [Related]

  • 24. The role of aspirin in cardiovascular prevention: implications of aspirin resistance.
    Gasparyan AY, Watson T, Lip GY.
    J Am Coll Cardiol; 2008 May 13; 51(19):1829-43. PubMed ID: 18466797
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. [Use of aspirin in diabetic patients].
    Türkoğlu S, Abaci A.
    Anadolu Kardiyol Derg; 2007 Dec 13; 7 Suppl 2():5-8. PubMed ID: 18160360
    [Abstract] [Full Text] [Related]

  • 27. Aspirin dose for prevention of cardiovascular disease in diabetics.
    Nowak SN, Jaber LA.
    Ann Pharmacother; 2003 Jan 13; 37(1):116-21. PubMed ID: 12503945
    [Abstract] [Full Text] [Related]

  • 28. Prevention of cardiovascular disease in type-2 diabetes: how to improve the clinical efficacy of aspirin.
    Evangelista V, Totani L, Rotondo S, Lorenzet R, Tognoni G, De Berardis G, Nicolucci A.
    Thromb Haemost; 2005 Jan 13; 93(1):8-16. PubMed ID: 15630484
    [Abstract] [Full Text] [Related]

  • 29. [Aspirin use in patients with diabetes mellitus].
    Sicras Mainar A, Ruiz Riera R, Frías Garrido X, Navarro Artieda R.
    Med Clin (Barc); 2004 Jul 10; 123(6):237; author reply 239. PubMed ID: 15282081
    [No Abstract] [Full Text] [Related]

  • 30. Fenofibrate for cardiovascular disease prevention in metabolic syndrome and type 2 diabetes mellitus.
    Steiner G.
    Am J Cardiol; 2008 Dec 22; 102(12A):28L-33L. PubMed ID: 19084087
    [Abstract] [Full Text] [Related]

  • 31. Assessing the risk/benefit profile before recommending aspirin for the primary prevention of cardiovascular events.
    Rodondi N, Bauer DC.
    Am J Med; 2004 Oct 01; 117(7):528-30. PubMed ID: 15464713
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Changing aspirin use in patients with Type 2 diabetes in the UKPDS.
    Cull CA, Neil HA, Holman RR.
    Diabet Med; 2004 Dec 01; 21(12):1368-71. PubMed ID: 15569143
    [Abstract] [Full Text] [Related]

  • 34. Diabetes as a 'cardiovascular disease equivalent': implications for treatment.
    Laakso M.
    Nat Clin Pract Cardiovasc Med; 2008 Nov 01; 5(11):682-3. PubMed ID: 18797431
    [Abstract] [Full Text] [Related]

  • 35. Glycemic targets for patients with type 2 diabetes mellitus.
    Hamnvik OP, McMahon GT.
    Mt Sinai J Med; 2009 Jun 01; 76(3):227-33. PubMed ID: 19421966
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Safety and tolerability of antiplatelet therapies for the secondary prevention of atherothrombotic disease.
    Spinler SA.
    Pharmacotherapy; 2009 Jul 01; 29(7):812-21. PubMed ID: 19558255
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Aspirin for the primary prevention of cardiovascular events: recommendations and rationale.
    U.S. Preventive Services Task Force.
    Am J Nurs; 2002 Mar 01; 102(3):67, 69-70. PubMed ID: 11976531
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.